pain de campagne
Selected indexed studies
- The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS project. (Ann Rheum Dis, 2025) [PMID:40107904]
- Development and validation of LUPIN: a patient-centred self-administered tool to assess disease activity and patient-reported outcomes in systemic lupus erythematosus. (RMD Open, 2025) [PMID:40992789]
- COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis. (Rheumatology (Oxford), 2023) [PMID:36315075]
_Worker-drafted node — pending editorial review._
Connections
pain de campagne helps
Sources
- The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS project. (2025) pubmed
- Development and validation of LUPIN: a patient-centred self-administered tool to assess disease activity and patient-reported outcomes in systemic lupus erythematosus. (2025) pubmed
- COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis. (2023) pubmed
- The voltage-gated sodium channel, para, limits Anopheles coluzzii vector competence in a microbiota dependent manner. (2023) pubmed
- Characteristics associated with patient delay during the management of ST-segment elevated myocardial infarction, and the influence of awareness campaigns. (2021) pubmed
- Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study. (2023) pubmed
- COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey. (2024) pubmed
- The Efficacy of Antivenin Latrodectus (Black Widow) Equine Immune F(ab')(2) Versus Placebo in the Treatment of Latrodectism: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial. (2019) pubmed
- Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study. (2024) pubmed
- COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study. (2022) pubmed